RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Sandy City, UT · +55 more sites
2 recruiting type 2 diabetes studies with a site in Sandy City, UT.
Sponsor: AstraZeneca
Sandy City, UT · +55 more sites
Sponsor: Novo Nordisk A/S
Salt Lake City, UT · Sandy City, UT · +96 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.